Abstract
Background
Esophageal cancers with a histological type other than the two major types, squamous cell carcinoma (SCC) and adenocarcinoma, are referred to as “special type of esophageal cancer” (STEC). STEC is rare and difficult to diagnose preoperatively. Therefore, we aimed to clarify the clinicopathological findings of STEC, including magnifying endoscopy with narrow band imaging (ME-NBI).
Methods
We reviewed 1133 lesions in 936 consecutive cases who underwent endoscopic resection or surgical resection for primary esophageal cancer. Patients were classified into the SCC group and the STEC group, respectively. Factors that predict STEC endoscopically, as well as clinicopathologic features of STEC compared to SCC, were examined.
Results
Twenty-eight STECs were diagnosed in 28 patients: 15 with basaloid squamous cell carcinoma, 6 with adenosquamous carcinoma, 4 with mucoepidermoid carcinoma, 1 with carcinosarcoma, 1 with salivary duct-type carcinoma, and 1 with neuroendocrine cell carcinoma. There was significantly more pT1b or deeper cancer (60.7% vs. 12.8%), lymphovascular invasion (50.0% vs. 11.1%) and elevated type (53.6% vs. 16.1%) in the STEC group. The proportion of lesions with type R vessels on ME-NBI was significantly higher in the STEC group (46.4% vs. 3.9%). The STEC group had significantly lower accuracy of ME-NBI for prediction of depth (64.3% vs. 83.5%) and a greater proportion of underestimated lesions (32.1% vs. 9.3%). In the multivariate analysis, the histopathology of STEC was associated with type R vessels on ME-NBI.
Conclusion
Type R vessels and submucosal tumor-like elevation might be the clinical predictors of STEC.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this article. Further enquiries can be directed to the corresponding author.
References
Japanese Classification of Esophageal Cancer. 11th Edition: part I. Esophagus. 2017;14(1):1–36.
Lokuhetty D, White VA, Watanabe R, et al. Digestive system tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2019.
Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.
Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2010. Esophagus. 2017;14(3):189–214.
Zhang HD, Chen CG, Gao YY, et al. Primary esophageal adenosquamous carcinoma: a retrospective analysis of 24 cases. Dis Esophagus. 2014;27(8):783–9.
Vos B, Rozema T, Miller RC, et al. Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study. Dis Esophagus. 2011;24(4):258–64.
Chen S, Chen Y, Yang J, et al. Primary mucoepidermoid carcinoma of the esophagus. J Thorac Oncol. 2011;6(8):1426–31.
Egashira A, Morita M, Kumagai R, et al. Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases. PLoS One. 2017;12(3): e0173501.
Jeene PM, Geijsen ED, Muijs CT, et al. Small cell carcinoma of the esophagus: a nationwide analysis of treatment and outcome at patient level in locoregional disease. Am J Clin Oncol. 2019;42(6):534–8.
Li TJ, Zhang YX, Wen J, et al. Basaloid squamous cell carcinoma of the esophagus with or without adenoid cystic features. Arch Pathol Lab Med. 2004;128(10):1124–30.
Ni PZ, Yang YS, Hu WP, et al. Primary adenosquamous carcinoma of the esophagus: an analysis of 39 cases. J Thorac Dis. 2016;8(10):2689–96.
Oguma J, Ozawa S, Kazuno A, et al. Clinicopathological features of superficial basaloid squamous cell carcinoma of the esophagus. Dis Esophagus. 2017;30(12):1–5.
Schizas D, Kapsampelis P, Mylonas KM. Adenosquamous carcinoma of the esophagus: a literature review. J Transl Int Med. 2018;6(2):70–3.
Suzuki Y, Nomura K, Matsui A, et al. Long-term outcomes of endoscopic submucosal dissection for special type of esophageal cancer. Dig Dis. 2023. https://doi.org/10.1159/000529590.
Inoue H, Honda T, Yoshida T, et al. Ultra-high magnification endoscopy of the normal esophageal mucosa. Dig Endosc. 1996;8(2):134–8.
Arima M, Tada M, Arima H. Evaluation of microvascular patterns of superficial esophageal cancers by magnifying endoscopy. Esophagus. 2005;2(4):191–7.
Inoue H. Magnification endoscopy in the esophagus and stomach. Dig Endosc. 2001;13(s1):S40–1.
Oyama T, Inoue H, Arima M, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus. 2017;14(2):105–12.
Goda K, Fujisaki J, Ishihara R, et al. Newly developed magnifying endoscopic classification of the Japan Esophageal Society to identify superficial Barrett’s esophagus-related neoplasms. Esophagus. 2018;15(3):153–9.
Goda K, Takeuchi M, Ishihara R, et al. Diagnostic utility of a novel magnifying endoscopic classification system for superficial Barrett’s esophagus-related neoplasms: a nationwide multicenter study. Esophagus. 2021;18:713–23.
Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12(1):1–30.
The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. GastrointestEndosc. 2003;58(6 Suppl):S3–43.
Yachida S, Nakanishi Y, Shimoda T, et al. Adenosquamous carcinoma of the esophagus. Clinicopathologic study of 18 cases. Oncology. 2004;66(3):218–25.
Huang Q, Wu H, Nie L, et al. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol. 2013;37(4):467–83.
Huang Q, Shi J, Sun Q, et al. Distal esophageal carcinomas in Chinese patients vary widely in histopathology, but adenocarcinomas remain rare. Hum Pathol. 2012;43(12):2138–48.
Funding
This study has not received any fundings.
Author information
Authors and Affiliations
Contributions
Conceptualization: YS. Methodology: YS. Investigation: all authors. Writing—original draft: YS. Writing—review and editing: YS. Approval of final manuscript: all authors.
Corresponding author
Ethics declarations
Ethical statement
The study was approved by the Institutional Review Board of Toranomon Hospital (approval number 2268) and was performed in accordance with the 1964 Declaration of Helsinki and its later revisions. All patients consented in writing to undergo the proposed procedure. Written informed consent for inclusion in the study was not mandatory in view of the retrospective observational nature of the research. However, patients were given the opportunity to opt out via the hospital’s website.
Conflict of interest
Yugo Suzuki, Yu Ohkura, Mako Koseki, Kosuke Nomura, Akira Matsui, Masaki Ueno, Daisuke Kikuchi, Kenichi Ohashi and Shu Hoteya declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Suzuki, Y., Ohkura, Y., Koseki, M. et al. Clinical predictors of special type of esophageal cancer. Esophagus 20, 484–491 (2023). https://doi.org/10.1007/s10388-023-01003-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-023-01003-1